Reliance Life Sciences Pvt. Ltd. - Product Pipeline Review

Global Markets Direct’s, ‘Reliance Life Sciences Pvt. Ltd. - Product Pipeline Review - 2016’, provides an overview of the Reliance Life Sciences Pvt. Ltd.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Reliance Life Sciences Pvt. Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Reliance Life Sciences Pvt. Ltd.

The report provides overview of Reliance Life Sciences Pvt. Ltd. including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Reliance Life Sciences Pvt. Ltd.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Reliance Life Sciences Pvt. Ltd.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Reliance Life Sciences Pvt. Ltd.’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Reliance Life Sciences Pvt. Ltd.

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Reliance Life Sciences Pvt. Ltd.’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Reliance Life Sciences Pvt. Ltd. Snapshot 5

Reliance Life Sciences ...

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Reliance Life Sciences Pvt. Ltd. Snapshot 5

Reliance Life Sciences Pvt. Ltd. Overview 5

Key Information 5

Key Facts 5

Reliance Life Sciences Pvt. Ltd. - Research and Development Overview 6

Key Therapeutic Areas 6

Reliance Life Sciences Pvt. Ltd. - Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products - Monotherapy 9

Pipeline Products - Out-Licensed Products 10

Out-Licensed Products/Combination Treatment Modalities 11

Reliance Life Sciences Pvt. Ltd. - Pipeline Products Glance 12

Reliance Life Sciences Pvt. Ltd. - Late Stage Pipeline Products 12

Phase III Products/Combination Treatment Modalities 12

Reliance Life Sciences Pvt. Ltd. - Clinical Stage Pipeline Products 13

Phase II Products/Combination Treatment Modalities 13

Reliance Life Sciences Pvt. Ltd. - Early Stage Pipeline Products 14

Preclinical Products/Combination Treatment Modalities 14

Discovery Products/Combination Treatment Modalities 15

Reliance Life Sciences Pvt. Ltd. - Unknown Stage Pipeline Products 16

Unknown Products/Combination Treatment Modalities 16

Reliance Life Sciences Pvt. Ltd. - Drug Profiles 17

cetuximab biosimilar 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

darbepoetin alfa 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

pegfilgrastim 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

etanercept biosimilar 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

Antisense RNAi Oligonucleotides for Undisclosed Indications 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

RSCL-0520 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

somatropin biosimilar 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

Monoclonal Antibodies for Oncology and Inflammation 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

RSCL-0521 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

NeuroRel 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

Reliance Life Sciences Pvt. Ltd. - Pipeline Analysis 27

Reliance Life Sciences Pvt. Ltd. - Pipeline Products by Target 27

Reliance Life Sciences Pvt. Ltd. - Pipeline Products by Route of Administration 28

Reliance Life Sciences Pvt. Ltd. - Pipeline Products by Molecule Type 29

Reliance Life Sciences Pvt. Ltd. - Pipeline Products by Mechanism of Action 30

Reliance Life Sciences Pvt. Ltd. - Dormant Projects 31

Reliance Life Sciences Pvt. Ltd. - Locations And Subsidiaries 32

Head Office 32

Other Locations & Subsidiaries 32

Appendix 34

Methodology 34

Coverage 34

Secondary Research 34

Primary Research 34

Expert Panel Validation 34

Contact Us 34

Disclaimer 35

List of Tables

List of Tables

Reliance Life Sciences Pvt. Ltd., Key Information 5

Reliance Life Sciences Pvt. Ltd., Key Facts 5

Reliance Life Sciences Pvt. Ltd. - ...

List of Tables

Reliance Life Sciences Pvt. Ltd., Key Information 5

Reliance Life Sciences Pvt. Ltd., Key Facts 5

Reliance Life Sciences Pvt. Ltd. - Pipeline by Indication, 2016 7

Reliance Life Sciences Pvt. Ltd. - Pipeline by Stage of Development, 2016 8

Reliance Life Sciences Pvt. Ltd. - Monotherapy Products in Pipeline, 2016 9

Reliance Life Sciences Pvt. Ltd. - Out-Licensed Products in Pipeline, 2016 10

Reliance Life Sciences Pvt. Ltd. - Out-Licensed Products/ Combination Treatment Modalities, 2016 11

Reliance Life Sciences Pvt. Ltd. - Phase III, 2016 12

Reliance Life Sciences Pvt. Ltd. - Phase II, 2016 13

Reliance Life Sciences Pvt. Ltd. - Preclinical, 2016 14

Reliance Life Sciences Pvt. Ltd. - Discovery, 2016 15

Reliance Life Sciences Pvt. Ltd. - Unknown, 2016 16

Reliance Life Sciences Pvt. Ltd. - Pipeline by Target, 2016 27

Reliance Life Sciences Pvt. Ltd. - Pipeline by Route of Administration, 2016 28

Reliance Life Sciences Pvt. Ltd. - Pipeline by Molecule Type, 2016 29

Reliance Life Sciences Pvt. Ltd. - Pipeline Products by Mechanism of Action, 2016 30

Reliance Life Sciences Pvt. Ltd. - Dormant Developmental Projects,2016 31

Reliance Life Sciences Pvt. Ltd., Other Locations 32

Reliance Life Sciences Pvt. Ltd., Subsidiaries 33

List of Figures

List of Figures

Reliance Life Sciences Pvt. Ltd. - Pipeline by Indication, 2016 7

Reliance Life Sciences Pvt. Ltd. - Pipeline by Stage of Development, ...

List of Figures

Reliance Life Sciences Pvt. Ltd. - Pipeline by Indication, 2016 7

Reliance Life Sciences Pvt. Ltd. - Pipeline by Stage of Development, 2016 8

Reliance Life Sciences Pvt. Ltd. - Monotherapy Products in Pipeline, 2016 9

Reliance Life Sciences Pvt. Ltd. - Pipeline by Target, 2016 27

Reliance Life Sciences Pvt. Ltd. - Pipeline by Route of Administration, 2016 28

Reliance Life Sciences Pvt. Ltd. - Pipeline by Molecule Type, 2016 29

Reliance Life Sciences Pvt. Ltd. - Pipeline Products by Mechanism of Action, 2016 30

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports